Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06865222 · ClinicalTrials.gov registry record · NA
Post COVID-19 Syndrome Treatment With Variable Pulse Transcranial Magnetic Stimulation
A NA study of Post COVID-19 Condition, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT06865222: Recruiting NA study of Post COVID-19 Condition, sponsored by Mayo Clinic.
NCT06865222 is a NA study of Post COVID-19 Condition that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06865222, a NA study of Post COVID-19 Condition, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to test if Variable Pulse TMS (Transcranial Magnetic Stimulation) can result in objective improvements in patients with Post COVID Syndrome (PCS).
Primary Outcome
Subjects in the Anosmia group will be assessed using the the University of Pennsylvania Smell Identification Test (UPSIT) test is commercially available booklet of 40 scratch-and-sniff odors, arranged in microencapsulated "scratch and sniff" format. Each correct identification is worth one point, with a score of 40 indicating a perfect smell. It has been used for the assessment of anosmia in COVID-19.
Conditions Studied
Interventions
- PROCEDURE Electromagnetic Brain Pulsing Variable Pulse Protocol (EMBP) - 2 weeks
- PROCEDURE Electromagnetic Brain Pulsing Variable Pulse Protocol (EMBP) - 4 weeks
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-07-22 |
| Est. Completion | 2027-04 |
| Phase | NA |
What NCT06865222 shows while recruiting
NCT06865222 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Post COVID-19 Condition appearing as the primary indexed condition, and to 2 interventions - of which Electromagnetic Brain Pulsing Variable Pulse Protocol (EMBP) - 2 weeks is the first listed.
NCT06865222 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT06865222 about?
NCT06865222 is a clinical study titled "Post COVID-19 Syndrome Treatment With Variable Pulse Transcranial Magnetic Stimulation". The purpose of this study is to test if Variable Pulse TMS (Transcranial Magnetic Stimulation) can result in objective improvements in patients with Post COVID Syndrome (PCS).
What is the current status of trial NCT06865222?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-07-22. Estimated completion is 2027-04.
What conditions does trial NCT06865222 study?
This clinical trial studies the following conditions: Post COVID-19 Condition.
What interventions are being tested in trial NCT06865222?
The interventions under investigation include: Electromagnetic Brain Pulsing Variable Pulse Protocol (EMBP) - 2 weeks (PROCEDURE), Electromagnetic Brain Pulsing Variable Pulse Protocol (EMBP) - 4 weeks (PROCEDURE).
Who is sponsoring clinical trial NCT06865222?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06865222 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post COVID-19 Condition
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06865222's enrollment target sits among peer trials
40 1448th of 2000 higher than 465 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Does a Technology Enabled Multi-disciplinary Team-based Care Model for the Management of Long COVID and Other Fatiguing Illnesses Improve Clinical Care of Patients and Represent a Sustainable Approach Within a Federally Qualified Health Center?
ACTIVE NOT RECRUITING · NA
-
Ventilatory and Perfusion Abnormalities in Individuals With Post-Acute Sequelae of SARS-CoV-2 Infection
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI